Inventiva (IVA) is trading down at $3.48 (-2.25%), as of the latest quote. It operates in the Health Care sector.
| FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | €3.20M | €7.00M | €372.0K | €4.19M | €12.2M | €17.5M | €9.20M |
| Growth (year over year) | — | +118.9% | −94.7% | +1027.4% | +190.4% | +43.5% | −47.4% |
| Operating income | −€32.9M | −€30.3M | −€29.7M | −€52.1M | −€57.1M | −€102.7M | −€97.6M |
| Operating margin | −1029.2% | −433.2% | −7988.7% | −1242.6% | −468.9% | −587.7% | −1060.6% |
| Net income | −€33.0M | −€30.2M | −€33.6M | −€49.6M | −€54.3M | −€110.4M | −€184.2M |
| Net margin | −1032.7% | −431.8% | −9037.4% | −1183.5% | −445.6% | −631.8% | −2002.7% |
| EPS (diluted) | −€1.61 | −€1.28 | −€0.99 | −€1.27 | −€1.31 | −€2.43 | −€3.08 |
| Balance sheet | |||||||
| Cash and equivalents | €56.7M | €35.8M | €105.7M | €86.6M | €86.7M | €26.9M | €96.6M |
| Total assets | €79.8M | €57.0M | €138.9M | €122.0M | €116.0M | €69.6M | €119.0M |
| Total liabilities | €18.2M | €15.6M | €27.7M | €33.1M | €70.5M | €101.6M | €225.6M |
| Shareholders' equity | €61.6M | €41.4M | €111.2M | €88.9M | €45.5M | −€32.0M | −€106.6M |
| Cash flow | |||||||
| Operating cash flow | −€34.2M | −€28.4M | −€30.6M | −€47.6M | −€44.9M | −€81.6M | −€85.9M |
From Inventiva's 20-F and 6-K filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Amounts are in Euro (EUR), as reported, not converted to dollars. Per-share figures are per ordinary share, which is not always the share traded in the US: an ADS can stand for several, or for part of one. Filings on SEC EDGAR →
No recent news mentioning Inventiva in our feed yet.